RBM5 and acute myeloid leukemia: Given the significant enrichment of HOXA9-related downstream targets from the GSEA analysis (Fig. 5c) and the rationale of the reporter-based screen, we proposed that HOXA9 might serve as a functional and direct target of RBM5 in AML.